{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:02:50Z","timestamp":1789909370199,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study was carried out to assess the impact of nickel nanoparticles (NiNPs) as well as scorpion venom on colorectal cancer (CRC) cells in the presence and\/or absence of 5-fluorouracil (5-FU), hydrogen sulfide (H<jats:sub>2<\/jats:sub>S), and nitric oxide (NO) donors and to determine alterations in endothelial NO synthase (eNOS) and cystathionine \u03b3-lyase (CSE) enzyme-producing genes in CRC patients. The IC<jats:sub>50<\/jats:sub> of both H<jats:sub>2<\/jats:sub>S and NO donors, along with NiNPs, were determined. The CRC cells were treated for 24hrs, and the cytotoxic activities were assessed using the MTT test. Moreover, the apoptosis was determined after 24hrs and 48hrs using TUNEL assay. Furthermore, the mutations in the eNOS gene (intron 4, -786T&gt;C and 894 G&gt;T) and CSE gene (1364GT) were determined using direct sequencing. The IC<jats:sub>50<\/jats:sub> values for sodium disulfide (Na<jats:sub>2<\/jats:sub>S) and sodium nitroprusside (SNP) at 24hrs treatment were found to be 5\u00a0mM and 10<jats:sup>\u22126<\/jats:sup>\u00a0M, respectively, while the IC<jats:sub>50<\/jats:sub> value for 5-FU was reached after 5-days of treatment in CRC cell line. Both black and yellow scorpion venoms showed no inhibition of cell proliferation after 24hrs treatment. Furthermore, Na<jats:sub>2<\/jats:sub>S showed a significant decrease in cell proliferation and an increase in apoptosis. Moreover, a co-treatment of SNP and 5-FU resulted in inhibition of the cytotoxic effect of 5-FU, while a combination treatment of NiNPs with Na<jats:sub>2<\/jats:sub>S, SNP, and 5-FU caused highly significant cytotoxicity. Direct sequencing reveals new mutations, mainly intronic variation in eNOS gene that has not previously been described in the database. These findings indicate that H<jats:sub>2<\/jats:sub>S promotes the anticancer efficiency of 5-FU in the presence of NiNPs while NO has antiapoptotic activity in CRC cell lines.<\/jats:p>","DOI":"10.1038\/s41598-021-82244-x","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:04:39Z","timestamp":1611831879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Zjwan","family":"Housein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayeb Sabir","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Salihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"82244_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"82244_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum, N. & Giovannucci, E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 16, 713\u2013732. https:\/\/doi.org\/10.1038\/s41575-019-0189-8 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"82244_CR3","doi-asserted-by":"publisher","first-page":"100221","DOI":"10.1016\/j.jcpo.2020.100221","volume":"24","author":"G Qader","year":"2020","unstructured":"Qader, G. et al. The status of cancer publications in the Kurdistan region of Iraq. J. Cancer Policy 24, 100221. https:\/\/doi.org\/10.1016\/j.jcpo.2020.100221 (2020).","journal-title":"J. Cancer Policy"},{"key":"82244_CR4","first-page":"1261","volume":"12","author":"RT Othman","year":"2011","unstructured":"Othman, R. T. et al. Cancer incidence rates in the Kurdistan region\/Iraq from 2007\u20132009. Asian Pac. J. Cancer Prev. APJCP 12, 1261\u20131264 (2011).","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"82244_CR5","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.7314\/apjcp.2015.16.18.8525","volume":"16","author":"N Khoshnaw","year":"2015","unstructured":"Khoshnaw, N., Mohammed, H. A. & Abdullah, D. A. Patterns of cancer in kurdistan: results of eight years cancer registration in Sulaymaniyah Province-Kurdistan-Iraq. Asian Pac. J. Cancer Prev. 16, 8525\u20138531. https:\/\/doi.org\/10.7314\/apjcp.2015.16.18.8525 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"82244_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.suronc.2016.05.009","volume":"25","author":"NK Kim","year":"2016","unstructured":"Kim, N. K. et al. Complete mesocolic excision and central vascular ligation for colon cancer: principle, anatomy, surgical technique, and outcomes. Surg. Oncol. 25, 252\u2013262. https:\/\/doi.org\/10.1016\/j.suronc.2016.05.009 (2016).","journal-title":"Surg. Oncol."},{"key":"82244_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"82244_CR8","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova, S. et al. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol. Ther. 206, 107447. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107447 (2020).","journal-title":"Pharmacol. Ther."},{"key":"82244_CR9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/cancers11081204","volume":"11","author":"Y-H Chen","year":"2019","unstructured":"Chen, Y.-H. et al. Maintenance BEZ235 treatment prolongs the therapeutic effect of the combination of BEZ235 and radiotherapy for colorectal cancer. Cancers 11, 1204. https:\/\/doi.org\/10.3390\/cancers11081204 (2019).","journal-title":"Cancers"},{"key":"82244_CR10","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","volume":"5","author":"J Tie","year":"2019","unstructured":"Tie, J. et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 5, 1710\u20131717. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3616 (2019).","journal-title":"JAMA Oncol."},{"key":"82244_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1358\/dot.2019.55.11.3035584","volume":"55","author":"F Shahjehan","year":"2019","unstructured":"Shahjehan, F., Kamatham, S., Chandrasekharan, C. & Kasi, P. M. Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer. Drugs Today (Barcelona, Spain: 1998) 55, 683\u2013693. https:\/\/doi.org\/10.1358\/dot.2019.55.11.3035584 (2019).","journal-title":"Drugs Today (Barcelona, Spain: 1998)"},{"key":"82244_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s12276-018-0128-8","volume":"50","author":"L He","year":"2018","unstructured":"He, L. et al. Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells. Exp. Mol. Med. 50, 101\u2013101. https:\/\/doi.org\/10.1038\/s12276-018-0128-8 (2018).","journal-title":"Exp. Mol. Med."},{"key":"82244_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10989-018-9721-x","volume":"25","author":"A Ghosh","year":"2019","unstructured":"Ghosh, A., Roy, R., Nandi, M. & Mukhopadhyay, A. Scorpion venom-toxins that aid in drug development: a review. Int. J. Pept. Res. Ther. 25, 27\u201337. https:\/\/doi.org\/10.1007\/s10989-018-9721-x (2019).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"82244_CR14","doi-asserted-by":"publisher","first-page":"102750","DOI":"10.1016\/j.micron.2019.102750","volume":"126","author":"H Xiao","year":"2019","unstructured":"Xiao, H., Chen, Y. & Alnaggar, M. Silver nanoparticles induce cell death of colon cancer cells through impairing cytoskeleton and membrane nanostructure. Micron 126, 102750. https:\/\/doi.org\/10.1016\/j.micron.2019.102750 (2019).","journal-title":"Micron"},{"key":"82244_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jtemb.2018.11.003","volume":"52","author":"S Khan","year":"2019","unstructured":"Khan, S. et al. Preparation, characterizations and in vitro cytotoxic activity of nickel oxide nanoparticles on HT-29 and SW620 colon cancer cell lines. J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elements (GMS) 52, 12\u201317. https:\/\/doi.org\/10.1016\/j.jtemb.2018.11.003 (2019).","journal-title":"J. Trace Elem. Med. Biol. Organ Soc. Miner. Trace Elements (GMS)"},{"key":"82244_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1089\/ars.2016.6909","volume":"26","author":"GK Kolluru","year":"2017","unstructured":"Kolluru, G. K., Shen, X., Yuan, S. & Kevil, C. G. Gasotransmitter heterocellular signaling. Antioxid. Redox Signal. 26, 936\u2013960. https:\/\/doi.org\/10.1089\/ars.2016.6909 (2017).","journal-title":"Antioxid. Redox Signal."},{"key":"82244_CR17","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/ptr.6378","volume":"33","author":"P Pietrangeli","year":"2019","unstructured":"Pietrangeli, P. et al. Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line Caco-2. Phytother. Res. PTR 33, 1878\u20131887. https:\/\/doi.org\/10.1002\/ptr.6378 (2019).","journal-title":"Phytother. Res. PTR"},{"key":"82244_CR18","doi-asserted-by":"publisher","first-page":"110096","DOI":"10.1016\/j.ecoenv.2019.110096","volume":"190","author":"K Li","year":"2020","unstructured":"Li, K. et al. Microcystins-LR induced apoptosis via S-nitrosylation of GAPDH in colorectal cancer cells. Ecotoxicol. Environ. Saf. 190, 110096. https:\/\/doi.org\/10.1016\/j.ecoenv.2019.110096 (2020).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"82244_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.niox.2019.03.002","volume":"87","author":"P Ehrenfeld","year":"2019","unstructured":"Ehrenfeld, P., Cordova, F., Duran, W. N. & Sanchez, F. A. S-nitrosylation and its role in breast cancer angiogenesis and metastasis. Nitric Oxide Biol. Chem. 87, 52\u201359. https:\/\/doi.org\/10.1016\/j.niox.2019.03.002 (2019).","journal-title":"Nitric Oxide Biol. Chem."},{"key":"82244_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrd.2015.1","volume":"15","author":"C Szabo","year":"2016","unstructured":"Szabo, C. Gasotransmitters in cancer: from pathophysiology to experimental therapy. Nat. Rev. Drug Discov. 15, 185\u2013203. https:\/\/doi.org\/10.1038\/nrd.2015.1 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"82244_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2017.7058","volume":"31","author":"X Cao","year":"2019","unstructured":"Cao, X. et al. A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer?. Antioxid. Redox Signal. 31, 1\u201338. https:\/\/doi.org\/10.1089\/ars.2017.7058 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"82244_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2209\/tdcpublication.2019-0003","volume":"60","author":"Y Ishizuka","year":"2019","unstructured":"Ishizuka, Y. et al. Expression profiles of NOS isoforms in dental pulp and odontoblasts in nNOS knockout mice. Bull. Tokyo Dent. College 60, 261\u2013266. https:\/\/doi.org\/10.2209\/tdcpublication.2019-0003 (2019).","journal-title":"Bull. Tokyo Dent. College"},{"key":"82244_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.cr.7290133","volume":"12","author":"W Xu","year":"2002","unstructured":"Xu, W., Liu, L. Z., Loizidou, M., Ahmed, M. & Charles, I. G. The role of nitric oxide in cancer. Cell Res. 12, 311\u2013320. https:\/\/doi.org\/10.1038\/sj.cr.7290133 (2002).","journal-title":"Cell Res."},{"key":"82244_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bcp.2017.10.011","volume":"149","author":"G Ol\u00e1h","year":"2018","unstructured":"Ol\u00e1h, G. et al. Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation. Biochem. Pharmacol. 149, 186\u2013204. https:\/\/doi.org\/10.1016\/j.bcp.2017.10.011 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"82244_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s1089-8603(02)00147-7","volume":"8","author":"P Chung","year":"2003","unstructured":"Chung, P. et al. Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide Biol. Chem. 8, 119\u2013126. https:\/\/doi.org\/10.1016\/s1089-8603(02)00147-7 (2003).","journal-title":"Nitric Oxide Biol. Chem."},{"key":"82244_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2147\/IJN.S123514","volume":"12","author":"AK Al-Asmari","year":"2017","unstructured":"Al-Asmari, A. K., Ullah, Z., Al Balowi, A. & Islam, M. In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach. Int. J. Nanomed. 12, 559\u2013574. https:\/\/doi.org\/10.2147\/IJN.S123514 (2017).","journal-title":"Int. J. Nanomed."},{"key":"82244_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4103\/0253-7613.190742","volume":"48","author":"AK Al-Asmari","year":"2016","unstructured":"Al-Asmari, A. K., Riyasdeen, A., Abbasmanthiri, R., Arshaduddin, M. & Al-Harthi, F. A. Scorpion (Androctonus bicolor) venom exhibits cytotoxicity and induces cell cycle arrest and apoptosis in breast and colorectal cancer cell lines. Indian J. Pharmacol. 48, 537\u2013543. https:\/\/doi.org\/10.4103\/0253-7613.190742 (2016).","journal-title":"Indian J. Pharmacol."},{"key":"82244_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.yexmp.2011.04.008","volume":"91","author":"J Zargan","year":"2011","unstructured":"Zargan, J. et al. Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. Exp. Mol. Pathol. 91, 447\u2013454. https:\/\/doi.org\/10.1016\/j.yexmp.2011.04.008 (2011).","journal-title":"Exp. Mol. Pathol."},{"key":"82244_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/DDDT.S231008","volume":"14","author":"AG Mikaelian","year":"2020","unstructured":"Mikaelian, A. G. et al. Pleiotropic anticancer properties of scorpion venom peptides: rhopalurus princeps venom as an anticancer agent. Drug Des. Devel. Ther. 14, 881\u2013893. https:\/\/doi.org\/10.2147\/DDDT.S231008 (2020).","journal-title":"Drug Des. Devel. Ther."},{"key":"82244_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu10050560","author":"S Attoub","year":"2018","unstructured":"Attoub, S., Arafat, K., Khalaf, T., Sulaiman, S. & Iratni, R. Frondoside a enhances the anti-cancer effects of oxaliplatin and 5-fluorouracil on colon cancer cells. Nutrients https:\/\/doi.org\/10.3390\/nu10050560 (2018).","journal-title":"Nutrients"},{"key":"82244_CR31","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1002\/jcb.26783","volume":"119","author":"E Kukcinaviciute","year":"2018","unstructured":"Kukcinaviciute, E. et al. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116. J. Cell Biochem. 119, 5913\u20135920. https:\/\/doi.org\/10.1002\/jcb.26783 (2018).","journal-title":"J. Cell Biochem."},{"key":"82244_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.042","volume":"149","author":"K Kashfi","year":"2018","unstructured":"Kashfi, K. The dichotomous role of H2S in cancer cell biology? Deja vu all over again. Biochem. Pharmacol. 149, 205\u2013223. https:\/\/doi.org\/10.1016\/j.bcp.2018.01.042 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"82244_CR33","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1073\/pnas.1306241110","volume":"110","author":"C Szabo","year":"2013","unstructured":"Szabo, C. et al. Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci USA 110, 12474\u201312479. https:\/\/doi.org\/10.1073\/pnas.1306241110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"82244_CR34","doi-asserted-by":"publisher","first-page":"45995","DOI":"10.1038\/srep45995","volume":"7","author":"R Miyamoto","year":"2017","unstructured":"Miyamoto, R. et al. Polysulfides (H(2)S(n)) produced from the interaction of hydrogen sulfide (H(2)S) and nitric oxide (NO) activate TRPA1 channels. Sci. Rep. 7, 45995. https:\/\/doi.org\/10.1038\/srep45995 (2017).","journal-title":"Sci. Rep."},{"key":"82244_CR35","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/1538-7445.AM2014-2513","volume":"74","author":"S Soyemi","year":"2014","unstructured":"Soyemi, S., Chattopadhyay, M. & Kashfi, K. NOSH-aspirin alone or in combination with 5-fluorouracil induces tumor regression in a xenograft model of estrogen receptor positive breast cancer. Can. Res. 74, 2513\u20132513. https:\/\/doi.org\/10.1158\/1538-7445.AM2014-2513 (2014).","journal-title":"Can. Res."},{"key":"82244_CR36","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.7150\/jca.35375","volume":"11","author":"T Yue","year":"2020","unstructured":"Yue, T. et al. Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS. J. Cancer 11, 1828\u20131838. https:\/\/doi.org\/10.7150\/jca.35375 (2020).","journal-title":"J. Cancer"},{"key":"82244_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","volume":"126","author":"M Estanqueiro","year":"2015","unstructured":"Estanqueiro, M., Amaral, M. H., Conceicao, J. & Sousa Lobo, J. M. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf. B Biointerfaces 126, 631\u2013648. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.12.041 (2015).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"82244_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","volume":"93","author":"E Perez-Herrero","year":"2015","unstructured":"Perez-Herrero, E. & Fernandez-Medarde, A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur. J. Pharm Biopharm. 93, 52\u201379. https:\/\/doi.org\/10.1016\/j.ejpb.2015.03.018 (2015).","journal-title":"Eur. J. Pharm Biopharm."},{"key":"82244_CR39","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.2147\/ijn.s200909","volume":"14","author":"SZ Abdulqadir","year":"2019","unstructured":"Abdulqadir, S. Z. & Aziz, F. M. Internalization and effects on cellular ultrastructure of nickel nanoparticles in rat kidneys. Int. J. Nanomed. 14, 3995\u20134005. https:\/\/doi.org\/10.2147\/ijn.s200909 (2019).","journal-title":"Int. J. Nanomed."},{"key":"82244_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1053\/j.seminoncol.2011.05.012","volume":"38","author":"P Bohanes","year":"2011","unstructured":"Bohanes, P., LaBonte, M. J., Winder, T. & Lenz, H. J. Predictive molecular classifiers in colorectal cancer. Semin. Oncol. 38, 576\u2013587. https:\/\/doi.org\/10.1053\/j.seminoncol.2011.05.012 (2011).","journal-title":"Semin. Oncol."},{"key":"82244_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2018.12.006","volume":"84","author":"J Nan","year":"2019","unstructured":"Nan, J., Liu, Y., Xu, C. & Ge, D. Effects of eNOS gene polymorphisms on individual susceptibility to cancer: a meta-analysis. Nitric Oxide Biol. Chem. 84, 1\u20136. https:\/\/doi.org\/10.1016\/j.niox.2018.12.006 (2019).","journal-title":"Nitric Oxide Biol. Chem."},{"key":"82244_CR42","doi-asserted-by":"publisher","first-page":"e972","DOI":"10.1097\/MD.0000000000000972","volume":"94","author":"X Gao","year":"2015","unstructured":"Gao, X., Wang, J., Wang, W., Wang, M. & Zhang, J. eNOS genetic polymorphisms and cancer risk: a meta-analysis and a case-control study of breast cancer. Medicine (Baltimore) 94, e972. https:\/\/doi.org\/10.1097\/MD.0000000000000972 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"82244_CR43","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.7314\/apjcp.2015.16.7.2929","volume":"16","author":"S Haque","year":"2015","unstructured":"Haque, S. et al. G894T and 4a\/b polymorphisms of NOS3 gene are not associated with cancer risk: a meta-analysis. Asian Pac. J. Cancer Prev. 16, 2929\u20132937. https:\/\/doi.org\/10.7314\/apjcp.2015.16.7.2929 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"82244_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12967-015-0619-5","volume":"13","author":"P Ulivi","year":"2015","unstructured":"Ulivi, P. et al. eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial. J. Transl. Med. 13, 258. https:\/\/doi.org\/10.1186\/s12967-015-0619-5 (2015).","journal-title":"J. Transl. Med."},{"key":"82244_CR45","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ijc.24114","volume":"124","author":"CC Yeh","year":"2009","unstructured":"Yeh, C. C., Santella, R. M., Hsieh, L. L., Sung, F. C. & Tang, R. An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int. J. Cancer 124, 1565\u20131571. https:\/\/doi.org\/10.1002\/ijc.24114 (2009).","journal-title":"Int. J. Cancer"},{"key":"82244_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jsps.2016.05.010","volume":"25","author":"E Tawfik","year":"2017","unstructured":"Tawfik, E., Ahamed, M., Almalik, A., Alfaqeeh, M. & Alshamsan, A. Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity. Saudi Pharm. J. 25, 206\u2013213. https:\/\/doi.org\/10.1016\/j.jsps.2016.05.010 (2017).","journal-title":"Saudi Pharm. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82244-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:46:04Z","timestamp":1670035564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82244-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82244"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82244-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"30 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2536"}}